Navigation Links
SDI Reports: Novo Nordisk Takes Top Ranking Among Endocrinologists, According To Pharmaceutical Company Image Study
Date:7/7/2010

Novo Nordisk was ranked by endocrinologists as the top company overall in a recent SDI study. Novo Nordisk increased sales calls to endocrinologists 30%.

(Vocus) July 7, 2010 -- According to SDI’s Pharmaceutical Company Image 2010 study, Novo Nordisk was ranked by endocrinologists as the top company overall. The company was mentioned by 62% of the endocrinologists who participated in the annual study – a substantial increase from last year, when it was mentioned by 52% of participants and ranked second.

Eli Lilly, ranked first by this specialty group in 2009, finished second this year even though its percentage of mentions was similar both years at 52% and 53%, respectively. Sanofi-aventis U.S. was ranked third.

During the 12 months ending April 2010, Lilly representatives made the most sales calls to endocrinologists, accounting for 12% of all calls to this specialty group, followed by Novo Nordisk, which accounted for 10%. The volume of calls made by each company increased from the previous 12 months, with Lilly's rising by 17% and Novo Nordisk’s by 30%.

When Novo representatives called on endocrinologists, the products they discussed most often were Levemir; Victoza which was launched in February 2010; and NovoLog.

SDI’s Company Image 2010, a comprehensive analysis of pharmaceutical company and industry image as perceived by key healthcare audiences, surveyed over 9,000 participants in March and April 2010, including physicians from 27 specialties, nurse practitioners, physician assistants, pharmacists, medical directors, pharmacy executives, and consumers, regarding their opinions of the pharmaceutical industry and industry trends.

The 2010 version represents the 11th edition of this landmark study that enables market researchers and brand management to:

 
  • Evaluate a company's overall image relative to market success and increases in prescribing.
  • Validate corporate initiatives to promote overall company image.
  • Understand the importance of company attributes among key customer groups.
  • Identify whether direct-to-consumer advertising drives consumer perceptions of pharmaceutical manufacturers.

About SDI

SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, retail pharmacy, and medical device companies, enabling them to better understand the healthcare market. SDI also serves the government and the financial services, media, and consumer packaged goods industries. Founded in 1982, SDI counts the world’s top 50 pharmaceutical and biotech firms as its clients.

###

Read the full story at http://www.prweb.com/releases/2010/SDICompanyImage/prweb4219854.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. CNBC Presents 'Tom Brokaw Reports: BOOMER$!' on Thursday, March 4th at 9PM ET/PT
2. SDI Reports: Nearly a Third Of Physicians Use Handheld and Smartphone Devices to Access Medical Information - Physicians Most Likely to be Using Apple iPhone
3. SDI Reports: Emergency Room Visits Covered by Medicaid Increased 6% in 2009
4. SDI Reports: Hospital Outpatient Surgical Procedures Increasing, Surgery Centers Growing
5. SDI Reports: Pharmaceutical Promotion Spending Indicates Trend Toward Electronic and Online Promotion
6. SDI Reports: Roughly Half of Patients Prescribed the Most Popular Osteoporosis Drugs Discontinue Therapy Within 6 Months -- Amgen's Prolia Offers New Dosing Option
7. Charlie Kimball Secures Partnership with Novo Nordisk, Maker of the Levemir FlexPen, for 2010 Firestone Indy Lights Campaign
8. Bioniche Achieves Two Additional Milestones Under Licensing Agreement; Endo Takes up Global Rights
9. AntiBiggestLoser.com; New Blog Takes Aim at Worldwide Reality TV Show, "The Biggest Loser"
10. USA's Greatest Speed Skater Takes His Medical Practice to the Cutting Edge
11. Global Nutrition Firm Takes Dose of SonicWALL to Boost Network Health
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
SDI Reports: Novo Nordisk Takes Top Ranking Among Endocrinologists, According To Pharmaceutical Company Image Study
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
Breaking Medicine Technology: